GenSight Biologics Alternatives & Competitors

12 companies similar to GenSight Biologics — Applying pathbreaking science to transform the lives of patients with severe ret...

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 Series C $341.00M

London, United Kingdom

Biotechnology Health Care +1

Compare

Ray Therapeutics, Inc.

Optogenetic Gene Therapy Company

46 Series B $235.00M

Berkeley, United States

Biotechnology Health Care +2

Compare

LambdaVision, Inc.

Leveraging Space to Restore Vision with a Protein-Based Artificial Retina

14 Seed $6.73M

Woodbridge, United States

Biotechnology Health Care

AAVantgarde

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...

70 Series A

Biotechnology Health Care +1

Compare

Track all GenSight Biologics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

SparingVision

Genomic Medicines For Ocular Diseases

49 Series B $119.50M

Paris, France

Biotechnology Health Care +1

Rocket Pharmaceuticals

Seeking gene therapy cures

222 IPO $725.80M

Cranbury, United States

Biotechnology Health Care +1

VeonGen Therapeutics GmbH

Dedicated to develop the medicines of the future

9 Series A

Planegg, Germany

Biotechnology Health Care +1

Exegenesis Bio

We are reimagining ways to develop & manufacture gene therapies. Our mission is to improv...

17 Series B

Philadelphia, United Stat...

Biotechnology Health Care +1

Ocular Therapeutix, Inc.

325 Post-IPO Equity $711.51M

Bedford, United States

Biotechnology Health Care +1

Passage Bio

Our mission is to improve the lives of patients with neurodegenerative diseases

43 Post-IPO Equity $379.50M

Philadelphia, United Stat...

Biotechnology Health Care +1

VectivBio

Biotech company develops treatments for severe rare diseases, aims to become global leader...

57 Acquired $1.29B

Basel, Switzerland

Biotechnology Health Care

Trefoil Therapeutics

Developing first-in-class investigational medicines for serious corneal diseases and disor...

11 Venture round $85.78M

San Diego, United States

Biotechnology Health Care +1

About GenSight Biologics

GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and optogenetics, the company is striving to preserve or restore vision in patients with degenerative retinal diseases. Its le...

Taxonomy

Clinical-stage Biotech, Gene Therapy, Retinal Diseases, Neurodegenerative Diseases, Mitochondrial Targeting Sequence, Optogenetics, Retinitis Pigmentosa, LHON, Gene Therapy-Based Treatments, Intravitreal Injection, Vision Restoration, Retinal Degeneration, Rare Diseases, Innovative Therapies

Frequently Asked Questions

Companies similar to GenSight Biologics include Beacon Therapeutics, Ray Therapeutics, Inc., LambdaVision, Inc., AAVantgarde, SparingVision. They work in Biotechnology and Health Care and share GenSight Biologics's focus on gene therapy, vision restoration and retinitis pigmentosa.

Bounce Watch lists 12 companies that share GenSight Biologics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches GenSight Biologics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

GenSight Biologics Profile Beacon Therapeutics Alternatives Ray Therapeutics, Inc. Alternatives AAVantgarde Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at GenSight Biologics on 11 Jun 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.